Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Anika Moorjani"'
Autor:
Timothy C. Chambers, Adam Huczyński, Angus M. MacNicol, Alicja Urbaniak, Anika Moorjani, Melanie C. MacNicol, Robert L. Eoff, Daniel Fil, Michał Sulik, Michalina Kupsik, Michał Antoszczak, Megan R. Reed, Sarah Heflin
Publikováno v:
Biomed Pharmacother
Biomedicine & Pharmacotherapy, Vol 141, Iss, Pp 111815-(2021)
Biomedicine & Pharmacotherapy, Vol 141, Iss, Pp 111815-(2021)
Breast cancer remains one of the leading cancers among women. Cancer stem cells (CSCs) are tumor-initiating cells which drive progression, metastasis, and reoccurrence of the disease. CSCs are resistant to conventional chemo- and radio-therapies and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ef21ed5bfec6bfee76c9cf62226cd89
https://europepmc.org/articles/PMC8429223/
https://europepmc.org/articles/PMC8429223/
Autor:
Adam Huczyński, Sergio Pina-Oviedo, Behjatolah Monzavi-Karbassi, Fariba Jousheghany, Timothy C. Chambers, Anika Moorjani, Greta Klejborowska, Alicja Urbaniak, Urszula Majcher‐Uchańska, Youzhong Yuan
Publikováno v:
Journal of biochemical and molecular toxicologyREFERENCES. 34(6)
Colchicine (COL) shows strong anticancer activity but due to its toxicity towards normal cells its wider application is limited. To address this issue, a library of 17 novel COL derivatives, namely N-carbamates of N-deacetyl-4-(bromo/chloro/iodo)thio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::414601bd073dd0b9cef7a4ed55f52198
https://pubmed.ncbi.nlm.nih.gov/32141170
https://pubmed.ncbi.nlm.nih.gov/32141170
